Bit · Endo

Multiple Endocrine Neoplasia — MEN 1, 2A, 2B

Three autosomal dominant syndromes that produce tumors in multiple endocrine glands. Each has a signature combination and a signature gene.

Mechanism

The MEN syndromes are autosomal dominant; each caused by a different gene with a stereotypical tumor portfolio:

Critical clinical point: in any patient with MEN 2A or 2B, prophylactic total thyroidectomy is recommended in early childhood (timing depends on specific RET codon) because medullary thyroid carcinoma is almost universal.

Differentiator Table

MEN 1MEN 2AMEN 2B
GeneMEN1 (tumor suppressor)RET (oncogene)RET (oncogene)
PituitaryYESNoNo
ParathyroidYES (hyperparathyroidism)YESNo
Pancreatic isletYES (gastrinoma, insulinoma)NoNo
Medullary thyroid carcinomaNoYESYES
PheochromocytomaNoYESYES
Mucosal/intestinal neuromas + marfanoidNoNoYES
Mnemonic3 Ps2 Ps + medullary1 P + medullary + Mucosal neuromas + Marfan

The Pivot

Pattern match the tumor portfolio:

  1. Hyperparathyroidism + pituitary adenoma + gastrinoma/insulinoma? → MEN 1.
  2. Medullary thyroid CA + pheo + parathyroid hyperplasia? → MEN 2A.
  3. Medullary thyroid CA + pheo + mucosal neuromas + tall thin habitus? → MEN 2B.

Whenever you see a young patient with pheo, screen for MEN 2A/2B (RET) and von Hippel-Lindau and NF1.

NBME-Style Stem

A 24-year-old man presents with episodic headaches, palpitations, and sweating. Examination reveals a tall, lanky build with long fingers, thickened lips with visible nodules on his tongue and lips, and a thyroid mass. 24-hour urinary metanephrines are elevated. Calcitonin is markedly elevated. Which of the following is the most likely diagnosis?
Concept Anchor
Three MEN syndromes, three predictable tumor combinations: MEN1 (3 Ps), MEN2A (medullary + pheo + parathyroid), MEN2B (medullary + pheo + neuromas + marfanoid). RET mutations drive 2A/2B; MEN1 mutation drives MEN1.

← Bit Library  ·  Log a missed question →